Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.

Database : the journal of biological databases and curation - 26 Jul 2021

Mittal Gauri, R I Anu, Vatsyayan Aastha, Pandhare Kavita, Scaria Vinod

Abstract excerpt

The steady increase in global cancer burden has fuelled the development of several modes of treatment for the disease. In the presence of an actionable mutation, targeted therapies offer a method to selectively attack cancer cells, increasing overall efficacy and reducing harmful side effects. However, different drug molecules are in different stages of development, with new molecules obtaining approvals from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Factual
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 34309639
DOI: 10.1093/database/baab042
PMCID: PMC8312254

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.PMID 34309639Read ↗

CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.Semantic proximity Read ↗

Targeting mutations in cancer.Semantic proximity Read ↗

Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data.Semantic proximity Read ↗

DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.Semantic proximity Read ↗

Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers.Semantic proximity Read ↗

CancerDR: cancer drug resistance database.Semantic proximity Read ↗

Methods and resources to access mutation-dependent effects on cancer drug treatment.Semantic proximity Read ↗

Passenger mutations as a target for the personalized therapy of cancerSemantic proximity Read ↗

DoCM: a database of curated mutations in cancerSemantic proximity Read ↗

Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases.Semantic proximity Read ↗

Pan-Cancer Integrative Analysis of Whole-Genome <em>De novo</em> Somatic Point Mutations Reveals 17 Cancer TypesSemantic proximity Read ↗

Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.